COVID-19 Mortality and Vaccine Coverage – Hong Kong Special Administrative Region, China, January 6, 2022-March 21, 2022COVID-19 사망률 및 백신 적용 범위 - 홍콩 특별 행정구, 중국, 2022년 1월 6일 - 2022년 3월 21일Article Published on 2022-04-152022-09-11 Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] age analyzed available data BNT162b2 booster booster dose cause caused China Cluster Coverage COVID-19 COVID-19 case COVID-19 cases COVID-19 mortality COVID-19 outbreak COVID-19 pandemic COVID-19 vaccine death declined Department dose doses driven by help high mortality highest Hong Kong identify inactivated Mortality mRNA vaccine occurred omicron Omicron variant overall mortality peaked Pfizer-BioNTech Prevent proportion recipient recipients Region reported resulting risk Sinovac vaccination Vaccine vaccine dose variant of SARS-CoV-2 virus [DOI] 10.15585/mmwr.mm7115e1 PMC 바로가기 [Article Type] Article
Increased COVID-19 mortality rate in rare disease patients: a retrospective cohort study in participants of the Genomics England 100,000 Genomes project희귀 질환 환자의 COVID-19 사망률 증가: Genomics England 100,000 Genomes 프로젝트 참가자의 후향적 코호트 연구Article Published on 2022-04-122022-09-11 Journal: Orphanet Journal of Rare Diseases [Category] COVID19(2023년), SARS, 유전자 메커니즘, [키워드] affected age Awareness calculated can not Cohort Comorbidities condition correlation COVID-19 COVID-19 mortality COVID-19 pandemic COVID-19 related mortality death disease Diseases disorders First wave Fisher Fisher's exact test Genomics England high risk Increased increased risk Logistic regression mortality rates multivariable analysis NEUROLOGY number of comorbidity pandemic participant Participants Patient patients performed positive raise rare disease rare diseases retrospective cohort study risk risk factor Risk factors significantly small sample size tested two groups univariable was used Workplace [DOI] 10.1186/s13023-022-02312-x PMC 바로가기 [Article Type] Article
Infection fatality rate and infection attack rate of COVID-19 in South American countries남미 국가에서 COVID-19의 감염 치사율 및 감염 공격 비율Article Published on 2022-04-062022-09-11 Journal: Infectious Diseases of Poverty [Category] COVID19(2023년), SARS, 변종, [키워드] affected analysed Analysis attack rate center country Coverage COVID-19 COVID-19 mortality COVID-19 outbreak COVID-19 pandemic dataset death deaths epidemic model epidemiological estimate fatality Fatality rate flexible Formula Health Organization help heterogeneous highest highlight IFR Infection Infection attack rate Infection fatality rate Johns Hopkin Johns Hopkins measure mortalities mortality rate MOST nonpharmaceutical intervention observé pandemic parameter Protective reductions reductions in reported reproduction Reproduction number retrieved reveal Severe infection severity situation social distancing South South America spatiotemporal suppress Surveillance text the disease transmission rate vaccination vaccination rate Variability variant World Health Organization [DOI] 10.1186/s40249-022-00961-5 PMC 바로가기 [Article Type] Article
Reduced COVID-19 mortality linked with early antibodies against SARS-CoV-2, irrespective of age연령에 관계없이 SARS-CoV-2에 대한 조기 항체와 연결된 COVID-19 사망률 감소Article Published on 2022-04-012022-09-11 Journal: European journal of internal medicine [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, 치료법, [키워드] Admission advanced age age Anti-spike antibody Antibody Response clinical assessment Clinical outcome co-morbidity Concentration COVID-19 COVID-19 infection COVID-19 mortality COVID-19 pandemic Cox regression model Critical death died discharged disease severity early phase early stage Efficiency elderly Elderly patient elderly patients functional healing hospital Hospital stay Hospitalization Humoral immunity IgG IgG levels IgM immune system Immunological response In-hospital death indicated lymphopenia modulate Mortality multivariate Multivariate Cox regression models Older outcome outcomes Patient produced PROTECT Protein risk risk factor SARS-CoV-2 serum Serum level serum levels stratified subject subjects therapeutic strategy titer [DOI] 10.1016/j.ejim.2022.02.010 PMC 바로가기 [Article Type] Article
Clinical outcomes of monoclonal antibody therapy during a COVID-19 outbreak in a skilled nursing facility-Arizona, 20212021년 애리조나주 전문 요양 시설에서 COVID-19 발생 시 단일 클론 항체 요법의 임상 결과Article Published on 2022-04-012022-09-11 Journal: Journal of the American Geriatrics Society [Category] COVID19(2023년), MERS, SARS, 변종, 진단, [키워드] adjusted Administered age association authorization bamlanivimab Care clinical Clinical outcome clinical outcomes Comorbidities Comorbidity COVID-19 COVID-19 disease COVID-19 mortality COVID-19 outbreak COVID-19 pandemic determine Effectiveness eligibility eligible Emergency Escalation EUA FDA group Immunotherapy IMPROVE increased risk information Logistic regression mAb medical record medical records Mild-to-moderate monoclonal antibody monoclonal antibody therapy morbidity and mortality Mortality multivariable logistic regression not significantly different outbreak outcome Outpatient oxygen Oxygen requirements Oxygen therapy receive reduced Referral resident SARS-COV-2 infection SARS-CoV-2 variant secondary Secondary outcomes severe COVID-19 disease Skilled nursing facilities therapy treated Treatment was used with COVID-19 [DOI] 10.1111/jgs.17705 PMC 바로가기 [Article Type] Article
Convalescent plasma therapy in patients with severe COVID-19, A single-arm, retrospective studyObservational Study Published on 2022-04-012022-10-04 Journal: Microbial pathogenesis [Category] COVID19(2023년), SARS, 바이오마커, 임상, [키워드] Admission age association Blood Group Characteristics Clinical outcome collected conditions conducted convalescent plasma COVID COVID-19 COVID-19 mortality CP therapy death demographic diagnosed dose Effect effective Effectiveness Efficacy evaluate Evidence hospital discharge Inflammatory biomarker Laboratory laboratory parameter median medical record Mortality Older age Other Patient plasma prothrombin randomized clinical trial respiratory retrospective cohort Retrospective study SARS-CoV-2 Secondary outcomes severe COVID-19 Sex significantly single-arm Stage suggested Symptom the disease therapy Treatment Treatment outcome Viral diseases [DOI] 10.1016/j.micpath.2022.105482 PMC 바로가기 [Article Type] Observational Study
Successful early use of anti-SARS-CoV-2 monoclonal neutralizing antibodies in SARS-CoV-2 infected hematological patients – A Czech multicenter experienceSARS-CoV-2에 감염된 혈액학적 환자에서 항-SARS-CoV-2 단일클론 중화 항체의 성공적인 조기 사용 - 체코의 다기관 경험Multicenter Study Published on 2022-04-012022-09-12 Journal: Hematological oncology [Category] COVID19(2023년), MERS, SARS, 진단, [키워드] administration analyzed anti-CD20 anti-SARS-CoV-2 anti-SARS-CoV-2 monoclonal neutralizing antibodies Asymptomatic asymptomatic patient bamlanivimab baseline Casirivimab Cohort Combination Course COVID-19 COVID-19 diagnosis COVID-19 mortality COVID-19 symptom Critical death diagnose diagnosed early administration early-stage COVID-19 Efficacy evaluated Final first COVID-19 symptom Follow-up General population hematological Hematological malignancy Imdevimab impair Infection leukemia leukemias lymphoma lymphomas median Mild moderate monoclonal monoclonal antibody monotherapy Mortality multicenter multicentre Neutralizing neutralizing antibody neutralizing monoclonal antibody nine occurred Patient patients plasma positive remained Result SARS-CoV-2 significantly significantly lower Spike protein survival rate therapy treated were recorded [DOI] 10.1002/hon.2974 PMC 바로가기 [Article Type] Multicenter Study
Global ecological analysis of COVID-19 mortality and comparison between “the East” and “the West” Research Published on 2022-03-282022-10-05 Journal: Scientific Reports [Category] SARS, 유전자 메커니즘, 치료기술, [키워드] adjusted Analysis autocorrelation baseline characteristics China coronavirus disease country COVID-19 COVID-19 mortality death determinants driver East ecological Epidemiology examined globe health system immunized median median age Mortality much higher multivariable National obesity output pandemic Prevalence Regression model reported response SARS-CoV-2 Significant Spread stability Study design sustained variable West [DOI] 10.1038/s41598-022-09286-7 [Article Type] Research
Humoral and cellular immunogenicity of SARS-CoV-2 vaccines in chronic lymphocytic leukemia: a prospective cohort study만성 림프구성 백혈병에서 SARS-CoV-2 백신의 체액 및 세포 면역원성: 전향적 코호트 연구Clinical Trial Published on 2022-03-222022-09-11 Journal: Blood advances [Category] MERS, SARS, 변종, 임상, 진단, [키워드] Absolute lymphocyte count accompanied acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibodies antibody Antibody Response Antibody responses assays bead-based multiplex immunoassay binding cellular characterization chronic chronic lymphocytic leukemia clinical benefit CLL CLL patient Cohort coronavirus COVID-19 mortality demonstrated develop dose elicited framework function functional IgG immunoassay induce interferon interferon-γ leukemia lymphocyte Lymphocytic leukemia molecular mechanism molecular mechanisms mRNA-based vaccine outcome Patient Previous studies previous study prospective cohort study provide RBD Receptor binding domain Registered respiratory response rate responses SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 vaccination SARS-CoV-2 vaccine Serologic response serologic responses severe acute respiratory syndrome Coronavirus Spike-specific T-cell responses T-cell T-cell Response T-cell responses tested Therapies therapy treatment-naïve patient treatment-naïve patients Trial vaccination Vaccine variant was performed wild-type [DOI] 10.1182/bloodadvances.2021006627 PMC 바로가기 [Article Type] Clinical Trial
COVID-19 mortality in Italy varies by patient age, sex and pandemic wave이탈리아의 COVID-19 사망률은 환자의 연령, 성별 및 유행성 유행에 따라 다릅니다.Article Published on 2022-03-172022-09-11 Journal: Scientific Reports [Category] SARS, 바이오마커, 치료기술, [키워드] affected age Analysis analyzed caused coronavirus disease Coronavirus disease-19 country COVID-19 COVID-19 mortality database death Deceased diagnosed Diagnosis Epidemic European Factor female First wave group higher risk Hospitalization Hospitalized Infection Italian Italy lower risk Male sex management Mortality mortality rate National Older pandemic Patient priority proportions risk factor SARS-CoV-2 Sex variable with COVID-19 [DOI] 10.1038/s41598-022-08573-7 PMC 바로가기 [Article Type] Article